Dudediligence.

NextCure, Inc

NXTCNASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Net income
−$42.7Mlast 12 months
Operating cash flow
−$50.0Mlast 12 months
Cash and equivalents
$15.3Mat the last balance sheet
Shares outstanding
4.1M shareson issue
Every year and quarter →